Short Communication - Journal of Translational Research (2022) Volume 6, Issue 6
The effect of COVID 19 on human cardiovascular health and behaviorsOphelia Atticus*
Department of Chemistry, Laboratory of Biochemistry, Atherothrombosis Research Centre, University of Ioannina, 45110 Ioannina, Greece
- *Corresponding Author:
- Ophelia Atticus
Department of Chemistry, Laboratory of Biochemistry
Atherothrombosis Research Centre
University of Ioannina, 45110 Ioannina, Greece
E-mail: [email protected]
Received: 24-Oct-2022, Manuscript No. AATR-22-79105; Editor assigned: 26-Oct-2022, Pre QC No. AATR-22-79105 (PQ); Reviewed: 09-Nov-2022, QC No. AATR-22-79105; Revised: 14-Nov -2022, Manuscript No. AATR-22-79105 (R); Published: 21-Nov-2022, DOI:10.35841/aatr-6.6.126
Citation: Atticus O. The effect of COVID 19 on human cardiovascular health and behaviors. Am J Transl Res. 2022;6(6):126
COVID-19, Human cardiovascular, Acute coronary syndrome.
We evaluated total cholesterin (TC), LDL-C, HDL cholesterin (HDL-C) and triglycerides (TG) in consecutive patients with FH before PCSK9-I treatment and when twelve (T12w) and thirty six (T36w) weeks of treatment. We have a tendency to evaluated LDL-C target accomplishment consistent with totally different mutations in LDLR. Eighty FH subjectsthirty- nine heterozygous (He) with defective LDLR factor mutations, thirty He with null mutations and eleven compound- He or homozygous (Ho) were recruited. At baseline, sixty nine subjects were below supreme lipoid lowering medical care (MLLT) and eleven subjects had statin-intolerance. From baseline to T36w we have a tendency to ascertained associate degree overall fifty one reduction in LDL-C. Proprotein convertase subtilisin/kexin kind nine inhibitors (PCSK9-I) incontestable effectiveness in beta-lipoprotein cholesterin (LDL-C) reduction and in hindrance of CV events [1,2].
The Spanish Society of vas & Endovascular Surgery presents the 2012-2019 report of the activity in inborn vas surgery supported a voluntary and anonymous registration involving the bulk of Spanish centres. This text is complementary to the 2019 vas surgery annual report and that they square measure revealed along. Information from the previous eight years square measure enclosed, so as to get real info associated with our activity in these comparatively scarce pathologies. Within the last eight years, a complete of sixteen, 917 inborn heart surgeries were performed, accounting for nine. 7% of surgery (congenital+acquired) performed in European nation throughout that amount. Of those surgeries, eighty one of them needed extracorporeal circulation and nineteen not. We have a tendency to highlight the interventions in neonates and adult patients that represent severally eighteen and twenty first of the total activity, and square measure a true challenge. The foremost current inborn heart pathologies operated on were body part defects in cases requiring extracorporeal circulation and ductus in patients not requiring extracorporeal circulation. The bestowed information square measure adjusted to the essential Aristotle score of surgical risk .
Cancer treatment is related to varied aspect effects of anticancer agents that increase the morbidity and mortality of those patients. Vas complications square measure thought of to be one among the foremost necessary aspect result of the antitumor medicine. The anticancer medicine that categorical vas effects embrace anthracyclines, aminoalkanoic acid enzyme inhibitors, taxanes, fluoropyrimidines, alkylating agents, vascular epithelium protein inhibitors, immune stop inhibitors, proteasome inhibitors and human stratum growth receptor kind two antibodies. The spectrum of vas effects of antitumor medicine is broad and embrace, among others, cardiopathy, arrhythmias like cardiac arrhythmia and chamber tachyarrhythmias, high blood pressure (systemic or pulmonary), heart disease, myocardial inflammation, valve unwellness, pericardiac unwellness, vascular events (arterial occlusion, blood vessel thromboembolism) and heart muscle anemia (acute coronary syndrome, angina) .
Social determinants of health square measure involved within the geographic variation in vas diseases (CVDs). The social vulnerability index (SVI) is associate degree estimate of a neighbourhood’s potential for hurtful outcomes once sweetfaced with natural disasters or unwellness outbreaks. We have a tendency to sought-after to research the association of the SVI with vas risk factors and therefore the prevalence of coronary cardiovascular disease (CHD) within the us at the census tract level. We have a tendency to connected census tract SVI with prevalence of census tract CVD risk factors (smoking, high cholesterin, diabetes, high pressure, low physical activity and obesity), and prevalence of CHD obtained from the activity risk issue closed-circuit television. We have a tendency to evaluate the association between SVI, its sub-scales, CVD risk factors and CHD prevalence victimisation regression. Among 72,173 census tracts, prevalence of all vas risk factors redoubled linearly with SVI .
- Canjar MR, Richard DL, Kappus RM. The impact of COVID-19 on cardiovascular health behaviors in student veterans. NMCD. 2022;32(3):727-3.
- Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. The lancet. 2020;395(10223):507-13.
- Gao J, Zheng P, Jia Y, et al. Mental health problems and social media exposure during COVID-19 outbreak. Plos one. 2020;15(4):e0231924.
- Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol. 2020;92(4):418-23.
- Zu ZY, Jiang MD, Xu PP, et al. Coronavirus disease 2019 (COVID-19): A perspective from China. Radiology. 2020;296(2):E15-25.